Breaking News: Report in the Journal of American Medical Association Finds Older Patients using Avandia at Risk of Serious Heart Problems, Death
BREAKING NEWS: A study in the December 12, 2007 issue of the Journal of
the American Medical Association (JAMA) has found that older patients
treated with diabetes medications known as thiazolidinediones (which include
rosiglitazone, brand name Avandia) had a significantly increased risk of heart
attack, congestive heart failure and death, compared with the use of other
drugs.
The study's authors conclude that the results present further
evidence that drugs such as Avandia may cause more harm than good.
The
study included 159,026 individuals with diabetes. Users of medicines with
rosiglitazone had a 60 percent increased risk of heart failure; a 40 percent
increased risk of heart attack; and a 29 percent increased risk of
death.
If you or a loved one has suffered cardiac complications after
ingesting Avandia, you deserve the guidance of a knowledgeable drug attorney.
Get a free case review by filling out the form below.
see also:
Sales Plunge
Report: Avandia's Sales Plunge After Study Raises Safety ConcernsStudy Suggested Avandia Had Safety Concerns, Raised Heart Attack Risk
Actos Study
Study: Actos Drug Controls Blood Sugar Levels Better than AvandiaResearch finds that Actos Drug is better at controling blood
News & Warnings
Avandia Breaking News: Glaxo Warned in 2001 about Misleading MarketingBloomberg News: FDA Warned Glaxo about Avandia Marketing in 2001


